Literature DB >> 17038947

Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients.

Shinji Nagata1, Toshio Matsushima, Takato Morioka, Koichiro Matsukado, Futoshi Mihara, Tomio Sasaki, Masashi Fukui.   

Abstract

OBJECTIVE: In unilaterally symptomatic moyamoya disease in children, it remains controversial whether bypass surgery should be performed on the asymptomatic side along with on the symptomatic side. We aimed to verify the validity of our strategy of only performing bypass surgery on the symptomatic side.
METHODS: Among 91 pediatric patients with moyamoya disease who underwent bypass surgery in our department between 1980 and 2004, 20 with unilateral ischemic symptoms who were followed for more than 60 months were analyzed in the present study. Initially, we only performed bypass surgery on the symptomatic side for all 20 patients. Among these 20 patients, five developed frequent transient ischemic attacks in the initially asymptomatic side and underwent a second bypass surgery on that side (Group A), eight developed sporadic transient ischemic attacks and were followed up without surgery (Group B), and seven did not experience any ischemic symptoms on the asymptomatic side (Group C).
RESULTS: In total, 18 patients progressed well without cerebral infarctions after their last surgery, although some showed deterioration of angiographic stenosis and a transient decrease in the regional cerebral blood flow or cerebral perfusion reserve. One patient in Group A had an intraventricular hemorrhage 5 years after the second operation, and one in Group B had a minor stroke on the initially asymptomatic side.
CONCLUSION: In unilaterally symptomatic moyamoya disease, bypass surgery for the asymptomatic side can be delayed until the development of ischemic symptoms, such as frequent transient ischemic attacks.

Entities:  

Mesh:

Year:  2006        PMID: 17038947     DOI: 10.1227/01.NEU.0000227527.69766.43

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Endovascular treatment of intracranial aneurysms associated with moyamoya disease or moyamoya syndrome.

Authors:  J-L Yu; H-L Wang; K Xu; Y Li; Q Luo
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

2.  Moyamoya syndrome associated with Graves' disease: a case series study.

Authors:  Jun Ni; Li-Xin Zhou; Yan-Ping Wei; Ming-Li Li; Wei-Hai Xu; Shan Gao; Li-Ying Cui
Journal:  Ann Transl Med       Date:  2014-08

3.  A genome-wide study of moyamoya-type cerebrovascular disease in the korean population.

Authors:  Sung-Pil Joo; Tae Sun Kim; Il-Kwon Lee; Joon-Tae Kim; Man-Seok Park; Ki-Hyun Cho
Journal:  J Korean Neurosurg Soc       Date:  2011-12-31

4.  Disappearance of a middle cerebral artery aneurysm associated with Moyamoya syndrome after revascularization in a child: case report.

Authors:  Johann Peltier; Matthieu Vinchon; Gustavo Soto-Ares; Patrick Dhellemmes
Journal:  Childs Nerv Syst       Date:  2008-07-12       Impact factor: 1.475

5.  Intraventricular hemorrhage long after successful encephaloduroarterio synangiosis in moyamoya patient.

Authors:  Moon Young Chung; Young Seok Park; Dong-Seok Kim; Joong-Uhn Choi
Journal:  J Korean Neurosurg Soc       Date:  2009-09-30

6.  Embolization with NBCA for Ruptured Aneurysm Located in the Moyamoya-like Collateral Network Associated with Isolated Middle Cerebral Artery Occlusion.

Authors:  Cheol Young Lee
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.